Previous Section
Review Articles
71. Combined targeted therapies in non-small cell lung cancer: a winner strategy?
- Author
- Cascone T; Gridelli C; Ciardiello F;
- Institution
- Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale F Magrassi e A Lanzara, Seconda Universita degli Studi di Napoli, Naples, Italy.
- Journal
- Curr Opin Oncol. 2007 Mar;19(2):98-102.
- Abstract URL
- Click here to view abstract
72. Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers.
- Author
- Huang CL; Yokomise H; Miyatake A;
- Institution
- Second Department of Surgery, Faculty of Medicine, Kagawa University, 1750-1, Mikicho, Kita-gun, Kagawa 761-0793, Japan. chuang@kms.ac.jp
- Journal
- Future Oncol. 2007 Feb;3(1):83-93.
- Abstract URL
- Click here to view abstract
73. Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: a meta-analysis.
- Author
- Mell LK; Malik R; Komaki R; Movsas B; Swann RS; Langer C; Antonadou D; Koukourakis M; Mundt AJ;
- Institution
- Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA. lmell@radonc.uchicago.edu
- Journal
- Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):111-8. Epub 2007 Feb 7.
- Abstract URL
- Click here to view abstract
74. Lung cancer in never smokers: a review.
- Author
- Subramanian J; Govindan R;
- Institution
- Department of Medicine and Alvin J. Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA.
- Journal
- J Clin Oncol. 2007 Feb 10;25(5):561-70.
- Abstract URL
- Click here to view abstract
75. Use of novel second-line targeted therapies in non-small cell lung cancer.
- Author
- Massarelli E; Herbst RS;
- Institution
- Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
- Journal
- Semin Oncol. 2006 Feb;33(1 Suppl 1):S9-16.
- Abstract URL
- Click here to view abstract
76. Second-line treatment options in non-small cell lung cancer: a comparison of cytotoxic agents and targeted therapies.
- Author
- de Marinis F; De Santis S; De Petris L;
- Institution
- 5th Pneumo-oncology Unit, Department of Oncology, S. Camillo-Forlanini Hospitals, Rome, Italy. demarinis.filippo@virgilio.it
- Journal
- Semin Oncol. 2006 Feb;33(1 Suppl 1):S17-24.
- Abstract URL
- Click here to view abstract
77. Advances in chemotherapy of non-small cell lung cancer.
- Author
- Molina JR; Adjei AA; Jett JR; Molina JR; Adjei AA; Jett JR; Molina JR; Adjei AA; Jett JR;
- Institution
- Division of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. molina.julian@mayo.edu
- Journal
- Chest. 2006 Oct;130(4):1211-9.
- Abstract URL
- Click here to view abstract
78. Recent developments in the chemotherapeutic options for nonsmall cell lung cancer.
- Author
- Ibrahim MN; Abdullah Z; Martin MJ;
- Institution
- Sligo General Hospital, The Medical Oncology Department, The Mall, Sligo, Co. Sligo, Ireland.
- Journal
- Expert Rev Anticancer Ther. 2006 Oct;6(10):1397-410.
- Abstract URL
- Click here to view abstract
79. Optimizing therapy in previously treated non-small cell lung cancer.
- Author
- Miller VA;
- Institution
- Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. millerv@mskcc.org
- Journal
- Semin Oncol. 2006 Feb;33(1 Suppl 1):S25-31.
- Abstract URL
- Click here to view abstract
